Session Details

[P1-05]Neuromuscular Disorders 1

Thu. Nov 19, 2026 4:00 PM - 5:00 PM JST
Thu. Nov 19, 2026 7:00 AM - 8:00 AM UTC
Exhibition Hall 1-A+2 (5) (Exhibition Hall 1-A+2, Exhibition Building, Sendai International Center)

[P1-05-01]Platform-specific characteristics in the analysis of pathogenic RFC1 repeat motifs using long read sequencing

Shunsuke Ogata1,2, Satoko Miyatake1,3, Kohei Hamanaka1, Kazuki Yamada1,4, Naomi Tsuchida1,5, Yuri Uchiyama1,5, Masamune Sakamoto1, Eriko Koshimizu1, Takeshi Mizuguchi1, Hiroshi Doi2, Fumiaki Tanaka2, Naomichi Matsumoto1,3,5 (1. Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2. Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 3. Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, Japan, 4. Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 5. Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan)

[P1-05-02]Urinary occult blood findings in spinal muscular atrophy patients treated with risdiplam

Toshio Saito1, Hisahide Nishio2 (1. Division of Child Neurology, Department of Neurology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan, 2. Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan)

[P1-05-03]A novel CTNNB1 variant in a patient with neurodevelopmental disorder and lower limb dystonia

Maki Nozaki1, Kyoko Hoshino1, Rina Shimomura2, Miho Nagata3, Yoshihiro Asano3,4, Masaharu Hayashi1, Toshiyuki Yamamoto2 (1. Segawa Memorial Neurological Clinic for Children, Tokyo, Japan, 2. Institute of Medical genetics, Tokyo Women's Medical University, Tokyo, Japan, 3. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan, 4. Department of Genomic Medicine, National Cerebral and Cardiovascular Center, Suita, Japan)

[P1-05-04]A pedigree of mild encephalitis/encephalopathy with a reversible splenial lesion with mutation p.Q403R of the MYRF gene

Yoshitsugu Nakamura1, Hirokazu Kurahashi2, Hiroki Itoh3, Takafumi Hosokawa1, Akihisa Okumura2, Shigeki Arawaka1 (1. Department of Internal Medicine IV, Division of Neurology, Osaka Medical and Pharmaceutical University, Osaka, Japan, 2. Department of Pediatrics, Aichi Medical University, Aichi, Japan, 3. Department of Neurology, Tenri Hospital, Nara, Japan)

[P1-05-05]A novel p.Gly42Cys SOD1 variant causing ALS with reduced thermal stability, aggregation propensity, and autopsy findings

Utako Nagaoka1, Asuka Funai1,2, Kentaro Kawama1, Kentaro Hayashi1, Kota Bokuda1, Kano Aikawa3, Yoshiaki Furukawa3, Nakamura Ryoichi4, Naoki Atsuta4, Genki Tohnai5, Airi Tarutani7, Masato Hasegawa7, Kenta Masui2,8, Takashi Komori2, Gen Sobue6, Kazushi Takahashi1, Keisuke Ishizawa2,9 (1. Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2. Department of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, 3. Department of Chemistry, Faculty of Science and Technology, Keio University, 4. Department of Neurology, Aichi Medical University School of Medicine, 5. Division of ALS Research, Aichi Medical University School of Medicine, 6. Aichi Medical University School of Medicine, 7. Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, 8. Department of Integrative Neuroscience, Graduate School of Biomedical Sciences, Nagasaki University, 9. Depatment of Pathology, Saitama Medical University)